At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Varithenadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study of the Effect of VarIthena® on Wound Healing in the Treatment of Venous Leg Ulcers Resulting From Chronic Venous Insufficiency
In Brief
An observational study evaluating Varithena for Venous Leg Ulcer. Completed, enrolled 76 participants across 14 sites in 2 countries.
Detailed Summary
A 12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting in VLU treated with Varithena.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Leg Ulcer
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartSep 2017
Primary CompletionMay 2020
Study CompletionSep 2020
TodayJul 2026
First PostedAug 22, 2017
Enrollment StartSep 29, 2017
Primary CompletionMay 18, 2020
Study CompletionSep 28, 2020
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 8.9 years ago
Interventions
Varithenadrug
Administration procedures and volume are per standard of care, full prescribing information, and instructions for use.